The effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid supplementation on muscle mass, strength, and power in resistance-trained individuals: a randomized, double-blind, placebo-controlled study

    Authors

    J. M. Wilson; R. P. Lowery; J. M. Joy; J. C. Andersen; S. M. C. Wilson; J. R. Stout; N. Duncan; J. C. Fuller; S. M. Baier; M. A. Naimo;J. Rathmacher

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    Eur. J. Appl. Physiol.

    Keywords

    Leucine metabolite; Resistance training; Overreaching; Recovery; Sports; supplements; ACTIVATED PROTEIN-KINASE; BODY-COMPOSITION; HMB SUPPLEMENTATION; EXERCISE; PERFORMANCE; DAMAGE; METABOLISM; INTENSITY; LEUCINE; MEN; Physiology; Sport Sciences

    Abstract

    Studies utilizing beta-hydroxy-beta-methylbutyrate (HMB) supplementation in trained populations are limited. No long-term studies utilizing HMB free acid (HMB-FA) have been conducted. Therefore, we investigated the effects of 12 weeks of HMB-FA supplementation on skeletal muscle hypertrophy, body composition, strength, and power in trained individuals. We also determined the effects of HMB-FA on muscle damage and performance during an overreaching cycle. A three-phase double-blind, placebo- and diet-controlled randomized intervention study was conducted. Phase 1 was an 8-week-periodized resistance-training program; Phase 2 was a 2-week overreaching cycle; and Phase 3 was a 2-week taper. Muscle mass, strength, and power were examined at weeks 0, 4, 8, and 12 to assess the chronic effects of HMB-FA; and assessment of these, as well as cortisol, testosterone, and creatine kinase (CK) was performed at weeks 9 and 10 of the overreaching cycle. HMB-FA resulted in increased total strength (bench press, squat, and deadlift combined) over the 12-week training (77.1 +/- A 18.4 vs. 25.3 +/- A 22.0 kg, p < 0.001); a greater increase in vertical jump power (991 +/- A 168 vs. 630 +/- A 167 W, p < 0.001); and increased lean body mass gain (7.4 +/- A 4.2 vs. 2.1 +/- A 6.1 kg, p < 0.001) in HMB-FA- and placebo-supplemented groups, respectively. During the overreaching cycle, HMB-FA attenuated increases in CK (-6 +/- A 91 vs. 277 +/- A 229 IU/l, p < 0.001) and cortisol (-0.2 +/- A 2.9 vs. 4.5 +/- A 1.7 mu g/dl, p < 0.003) in the HMB-FA- and placebo-supplemented groups, respectively. These results suggest that HMB-FA enhances hypertrophy, strength, and power following chronic resistance training, and prevents decrements in performance following the overreaching.

    Journal Title

    European Journal of Applied Physiology

    Volume

    114

    Issue/Number

    6

    Publication Date

    1-1-2014

    Document Type

    Article

    Language

    English

    First Page

    1217

    Last Page

    1227

    WOS Identifier

    WOS:000336220900012

    ISSN

    1439-6319

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.